We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+21.59%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$755M
AUM Growth
-$233M
(-24%)
Cap. Flow
-$241M
Cap. Flow
% of AUM
-31.95%
Top 10 Holdings %
Top 10 Hldgs %
44.11%
Holding
104
New
30
Increased
5
Reduced
45
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$4.01M |
| 2 |
AKYA
Akoya BioSciences
AKYA
|
+$2.41M |
| 3 |
ABCM
Abcam PLC
ABCM
|
+$2.17M |
| 4 |
Alphatec Holdings
ATEC
|
+$2.07M |
| 5 |
AMN Healthcare
AMN
|
+$1.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quanterix
QTRX
|
+$22.5M |
| 2 |
Establishment Labs
ESTA
|
+$16.1M |
| 3 |
Glaukos
GKOS
|
+$15.8M |
| 4 |
Inspire Medical Systems
INSP
|
+$11.3M |
| 5 |
LivaNova
LIVN
|
+$8.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.02% |
| 2 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
iShares S&P 100 ETF
OEF
$20.4B
| $63.1M | 8.36% |
337,000
-13,000
| -4% | -$2.53M |
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$819B
| $46.2M | 6.12% |
104,300
-63,700
| -38% | -$26.7M |
|
3
PUT
Invesco QQQ Trust
QQQ
$480B
| $39.5M | 5.23% |
106,900
-78,100
| -42% | -$26.3M |
|
|
4
Establishment Labs
ESTA
$2.69B
| $33.5M | 4.43% |
488,018
-232,897
| -32% | -$16.1M |
|
5
PUT
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
| $30.8M | 4.08% |
284,300
-140,700
| -33% | -$7.3M |
|
6
PUT
iShares Morningstar Value ETF
ILCV
$1.35B
| $29.6M | 3.93% |
525,000
-563,000
| -52% | -$36.3M |
|
|
7
Quanterix
QTRX
$177M
| $24.9M | 3.29% |
1,102,062
-1,260,244
| -53% | -$22.5M |
|
8
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.3B
| $23.8M | 3.15% |
179,000
-21,000
| -11% | -$2.77M |
|
9
PUT
Thermo Fisher Scientific
TMO
$214B
| $20.9M | 2.76% |
+40,000
| New | +$21.6M |
|
|
10
Glaukos
GKOS
$10.1B
| $20.9M | 2.76% |
292,849
-275,042
| -48% | -$15.8M |
|
11
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.21B
| $20.7M | 2.74% |
248,300
-51,700
| -17% | -$6.49M |
|
|
CUTR
12
DELISTED
Cutera, Inc.
CUTR
| $19.1M | 2.53% |
1,263,602
+43,227
| +4% | +$819K |
|
|
13
Inspire Medical Systems
INSP
$1.74B
| $17.9M | 2.37% |
55,171
-39,722
| -42% | -$11.3M |
|
|
14
CALL
LivaNova
LIVN
$4.29B
| $17.9M | 2.37% |
347,800
+297,800
| +596% | +$14M |
|
15
PUT
Stryker
SYK
$129B
| $16.5M | 2.18% |
+54,000
| New | +$15.6M |
|
16
PUT
Danaher
DHR
$140B
| $16.2M | 2.15% |
+76,140
| New | +$16.1M |
|
|
17
CALL
Glaukos
GKOS
$10.1B
| $15.5M | 2.06% |
218,200
+53,400
| +32% | +$3.07M |
|
18
CALL
ICU Medical
ICUI
$4.16B
| $15.3M | 2.03% |
85,900
-14,100
| -14% | -$2.59M |
|
19
PUT
Mettler-Toledo International
MTD
$28.5B
| $14.4M | 1.91% |
+11,000
| New | +$15.5M |
|
20
PUT
ARK Genomic Revolution ETF
ARKG
$1.66B
| $11.9M | 1.58% |
348,900
-226,100
| -39% | -$7.11M |
|
21
Outset Medical
OM
$96.8M
| $11.9M | 1.57% |
36,205
-25,071
| -41% | -$7.65M |
|
|
RCM
22
DELISTED
R1 RCM Inc. Common Stock
RCM
| $11M | 1.46% |
596,282
-168,418
| -22% | -$2.74M |
|
23
PUT
ARK Innovation ETF
ARKK
$6.05B
| $11M | 1.46% |
248,900
-251,100
| -50% | -$9.98M |
|
|
24
LivaNova
LIVN
$4.29B
| $10.8M | 1.43% |
210,363
-190,607
| -48% | -$8.95M |
|
25
Natera
NTRA
$39.3B
| $9.74M | 1.29% |
200,094
-36,336
| -15% | -$1.85M |
|
Similar funds
GMP
BCA
ONGA
RC
DOFI
SR
PA
SCI
Pura Vida Investments's Q2 2023 Portfolio in Review
As of Q2 2023, Pura Vida Investments held 104 positions worth $755M, down 24% from $988M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Pura Vida Investments withdrew a net $241M in Q2 2023, closing 18 positions and reducing 45 holdings. Its most notable exit was Transmedics, an estimated $4.17M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Industrials.
Against the trend, Pura Vida Investments opened a new position in Guardant Health worth $5M.
- Pura Vida Investments's largest Q2 2023 buy was Guardant Health: 139,591 shares worth $5M.
- Pura Vida Investments added most to Cutera, Inc. in Q2 2023, an estimated $819K increase.
- Pura Vida Investments's biggest Q2 2023 reduction was Quanterix, cutting an estimated $22.5M.
- Pura Vida Investments fully exited Transmedics in Q2 2023, selling an estimated $4.17M.
- Pura Vida Investments's ten largest holdings make up 44% of its $755M portfolio in Q2 2023.
- Pura Vida Investments opened 30 new positions and closed 18 in Q2 2023.
- Pura Vida Investments's portfolio value fell 24% quarter-over-quarter to $755M.
Based on Pura Vida Investments's 13F filing for Q2 2023, filed 14 Aug 2023.